tiprankstipranks
Trending News
More News >
Anbio Biotechnology Class A (NNNN)
:NNNN
US Market

Anbio Biotechnology Class A (NNNN) Similar Stocks

Compare
21 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Anbio Biotechnology Class A
$6.93
$5.32B
610.40
HealthStream
$27.80
$848.60M
44.49
0.43%
2 Buy
2 Hold
0 Sell
Moderate Buy
US Physical Therapy
$82.14
$1.25B
37.80
-8.78%
4 Buy
1 Hold
0 Sell
Strong Buy
Spyre Therapeutics
$15.76
$951.17M
2.31
-40.44%
8 Buy
1 Hold
0 Sell
Strong Buy
RxSight
$13.05
$530.31M
-77.09%
3 Buy
3 Hold
1 Sell
Moderate Buy
Structure Therapeutics, Inc. Sponsored ADR
$20.36
$1.17B
-45.30%
12 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NNNN
Anbio Biotechnology Class A
36.99
31.32
552.38%
HSTM
HealthStream
27.80
0.12
0.43%
USPH
US Physical Therapy
82.14
-7.91
-8.78%
SYRE
Spyre Therapeutics
15.76
-10.70
-40.44%
RXST
RxSight
13.05
-43.90
-77.09%
GPCR
Structure Therapeutics, Inc. Sponsored ADR
20.36
-16.87
-45.31%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis